19
Pediatric Dosage beyond the
Neonatal Period
a
Antimicrobial Agent for Patients with
Severe Penicillin Hypersensitivity
60-75 mg/kg/dose of the piperacillin
component q6h IV
10-13 mg/kg/dose q8h IV
Clindamycin or metronidazole
b
with an
aminoglycoside or fluoroquinolone.
N/A N/A
20 mg/kg/dose q8h IV N/A
15 mg/kg/dose q12h IV for children
3 months to 12 years
N/A
50 mg/kg/dose q6h IV
7.5 mg/kg/dose q6h IV
10-13 mg/kg/dose q8h IV
N/A
60,000-100,000 u/kg/dose q6h IV
10-13 mg/kg/dose q8h IV
Vancomycin, linezolid, quinupristin/
dalfopristin, daptomycin
50 mg/kg/dose q6h IV Vancomycin, linezolid, quinupristin/
dalfopristin, daptomycin
50 mg/kg/dose q6h IV
33 mg/kg/dose q8h IV
15 mg/kg/dose q6h IV N/A
10-13 mg/kg/dose q8h IV Bacteriostatic; potential cross-resistance and
emergence of resistance in erythromycin-
resistant strains; inducible resistance in MRSA.
c
10-13 mg/kg/dose q8h IV
60,000-100,00 u/kg/dose q6h IV
N/A
NOT recommended for children, but
may need to use in life-threatening
situations.
N/A
NOT recommended for children, but
may need to use in life-threatening
situations.
N/A
